AMS saw its Momentum Indicator move below the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 138 similar instances where the indicator turned negative. In 97 of the 138 cases, the stock moved further down in the following days. The odds of a decline are at 70%.
The Moving Average Convergence Divergence Histogram (MACD) for AMS turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 32 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for AMS entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for AMS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMS advanced for three days, in 127 of 200 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
AMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.334) is normal, around the industry mean (204.532). P/E Ratio (-4.462) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (2.498). Dividend Yield (0.164) settles around the average of (0.154) among similar stocks. P/S Ratio (0.313) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. AMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where UHS declined for three days, in 186 of 283 cases, the price declined further within the following month. The odds of a continued downward trend are 66%.
The 10-day RSI Indicator for UHS moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 25 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
UHS broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on UHS as a result. In 67 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for UHS just turned positive on November 04, 2026. Looking at past instances where UHS's MACD turned positive, the stock continued to rise in 28 of 42 cases over the following month. The odds of a continued upward trend are 67%.
UHS moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 50-day moving average for UHS moved above the 200-day moving average on October 27, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +12.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHS advanced for three days, in 240 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 212 of 298 cases where UHS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. UHS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 45 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.533) is normal, around the industry mean (204.532). P/E Ratio (7.893) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (1.197) is also within normal values, averaging (2.498). Dividend Yield (0.004) settles around the average of (0.154) among similar stocks. P/S Ratio (0.621) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
AMS | UHS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 89 | 72 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 5 Undervalued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 59 | |
SMR RATING 1..100 | 93 | 45 | |
PRICE GROWTH RATING 1..100 | 75 | 43 | |
P/E GROWTH RATING 1..100 | 20 | 78 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMS's Valuation (5) in the Medical Or Nursing Services industry is somewhat better than the same rating for UHS (61) in the Hospital Or Nursing Management industry. This means that AMS’s stock grew somewhat faster than UHS’s over the last 12 months.
UHS's Profit vs Risk Rating (59) in the Hospital Or Nursing Management industry is somewhat better than the same rating for AMS (100) in the Medical Or Nursing Services industry. This means that UHS’s stock grew somewhat faster than AMS’s over the last 12 months.
UHS's SMR Rating (45) in the Hospital Or Nursing Management industry is somewhat better than the same rating for AMS (93) in the Medical Or Nursing Services industry. This means that UHS’s stock grew somewhat faster than AMS’s over the last 12 months.
UHS's Price Growth Rating (43) in the Hospital Or Nursing Management industry is in the same range as AMS (75) in the Medical Or Nursing Services industry. This means that UHS’s stock grew similarly to AMS’s over the last 12 months.
AMS's P/E Growth Rating (20) in the Medical Or Nursing Services industry is somewhat better than the same rating for UHS (78) in the Hospital Or Nursing Management industry. This means that AMS’s stock grew somewhat faster than UHS’s over the last 12 months.
| AMS | UHS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 57% |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 70% | 1 day ago 71% |
| MACD ODDS (%) | 1 day ago 67% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 62% | 1 day ago 65% |
| TrendMonth ODDS (%) | 1 day ago 65% | 1 day ago 70% |
| Advances ODDS (%) | 16 days ago 63% | 8 days ago 72% |
| Declines ODDS (%) | 7 days ago 65% | 16 days ago 66% |
| BollingerBands ODDS (%) | 1 day ago 76% | 1 day ago 57% |
| Aroon ODDS (%) | 1 day ago 67% | 1 day ago 71% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMS’s FA Score shows that 2 FA rating(s) are green while UHS’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMS’s TA Score shows that 4 TA indicator(s) are bullish while UHS’s TA Score has 6 bullish TA indicator(s).
AMS (@Hospital/Nursing Management) experienced а -6.84% price change this week, while UHS (@Hospital/Nursing Management) price change was -2.39% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -6.21%. For the same industry, the average monthly price growth was -1.10%, and the average quarterly price growth was +8.43%.
AMS is expected to report earnings on Apr 06, 2027.
UHS is expected to report earnings on Mar 03, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, UHS has been closely correlated with HCA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if UHS jumps, then HCA could also see price increases.
| Ticker / NAME | Correlation To UHS | 1D Price Change % | ||
|---|---|---|---|---|
| UHS | 100% | -1.49% | ||
| HCA - UHS | 68% Closely correlated | -1.06% | ||
| THC - UHS | 57% Loosely correlated | -2.09% | ||
| CHE - UHS | 43% Loosely correlated | -0.08% | ||
| PNTG - UHS | 42% Loosely correlated | -2.42% | ||
| ENSG - UHS | 41% Loosely correlated | +0.19% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UJAN | 46.64 | -0.07 | -0.15% |
| Innovator U.S. Equity Ultra Buffer ETF - January (UJAN) | |||
| ITDG | 41.95 | -0.24 | -0.57% |
| iShares LifePath Target Date 2055 ETF (ITDG) | |||
| CVLC | 93.62 | -0.59 | -0.62% |
| Calvert US Large-Cap Core Responsible Index ETF (CVLC) | |||
| IEFA | 96.76 | -0.67 | -0.69% |
| iShares Core MSCI EAFE ETF (IEFA) | |||
| HBMX | 18.61 | -0.47 | -2.48% |
| Tuttle Capital Concentrated Memory Stack ETF (HBMX) | |||